Chris Wolfe - Chief Financial Officer at DA32 Life Science Tech Acquisition Corp.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Chris Wolfe since 05 Sep 2025

Reported holdings for Chris Wolfe in DA32 Life Science Tech Acquisition Corp.

Form 4 holding Chief Financial Officer

DA32 Life Science Tech Acquisition Corp.

Security class
Class B Common Stock, par value $0.0001 per share
Shares / value
125,000
Estimated value
$1,250,000
Report date
05 Aug 2021
Price
$10.00
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Transaction history for Chris Wolfe in DA32 Life Science Tech Acquisition Corp.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .